Literature DB >> 6573927

Comparison of radioimmunological determinations with gas chromatography mass spectrometry dosage. A study of PGE2 and PGF2alpha in gastrointestinal fluids.

K Bukhave, K Gréen, J Rask-Madsen.   

Abstract

The reliability of radioimmunoassays for determination of PGE2 and PGF2alpha in gastrointestinal fluids was checked by two gas chromatographic mass spectrometric methods. Analyses were performed on samples of gastric juice from dogs and man (healthy volunteers), jejunal fluids from patients with celiac disease, mucous discharge from a villous adenoma of rectum, and bathing solutions from the Ussing chamber containing human jejunal mucosa. The radioimmunoassays included extraction and Sephadex LH-20 chromatography as a preliminary purification before quantification was carried out. Gas chromatographic mass spectrometric analysis of PGE2 was performed by monitoring the molecular ion of the trimethylsilyl ether of PGB2 methyl ester, m/z 420 and m/z 424 for the protium and the deuterium form, respectively, while PGF2alpha was quantified as the triacetyl derivative of the methyl ester, using the ion pair (M-3x60) i.e. m/z 314 and m/z 318. Recovery of immunoreactive PGE2 relative to gas chromatographic mass spectrometric dosage was 85.5% + / - 6.5 (mean + / - SEM; n=13), while the amount of PGF2alpha in the same sample volume was at the borderline of sensitivity for the gas chromatographic mass spectrometric method used, with a recovery of 114% + / - 19 (mean + / - SEM; n=4).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6573927     DOI: 10.1002/bms.1200100406

Source DB:  PubMed          Journal:  Biomed Mass Spectrom        ISSN: 0306-042X


  13 in total

1.  In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

2.  Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

3.  Prostaglandin E2 is a mediator of 5-hydroxytryptamine induced water and electrolyte secretion in the human jejunum.

Authors:  L K Munck; A Mertz-Nielsen; H Westh; K Bukhave; E Beubler; J Rask-Madsen
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

4.  Colonic transport of water and electrolytes in a patient with secretory diarrhea due to collagenous colitis.

Authors:  J Rask-Madsen; O Grove; M G Hansen; K Bukhave; C Scient; R Henrik-Nielsen
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

5.  Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera.

Authors:  F P Van Loon; G H Rabbani; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

6.  Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.

Authors:  K Lauritsen; L Staerk Laursen; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

7.  Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.

Authors:  K Lauritsen; J Hansen; P Bytzer; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

8.  Increased jejunal prostaglandin E2 concentrations in patients with acute cholera.

Authors:  P Speelman; G H Rabbani; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

9.  Muscarinic M1 receptor inhibition reduces gastroduodenal bicarbonate secretion and promotes gastric prostaglandin E2 synthesis in healthy volunteers.

Authors:  A Mertz-Nielsen; J Hillingsø; O Eskerod; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

10.  Prostaglandin E2 formation by the gall bladder in experimental cholecystitis.

Authors:  E Thornell; L Jivegård; K Bukhave; J Rask-Madsen; J Svanvik
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.